EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 23 / No 11 (Novembre 2007) Med Sci (Paris), 23 11 (2007) 991-996 References
Free Access
Issue
Med Sci (Paris)
Volume 23, Number 11, Novembre 2007
Page(s) 991 - 996
Section M/S revues
DOI https://doi.org/10.1051/medsci/20072311991
Published online 15 November 2007
  1. Oleske J, Minefor A, Cooper R, et al. Immune deficiency syndrome in children. JAMA 1983; 249 : 2345–9. [Google Scholar]
  2. Cowan MJ, Hellmann D, Chudwin D, et al. Maternal transmission of acquired immune deficiency syndrome. Pediatrics 1984; 73 : 382–6. [Google Scholar]
  3. Lapointe N, Michaud J, Pekovic D, et al. Transplacental transmission of HTLV-III virus. N Engl J Med 1985; 312 : 1325–6. [Google Scholar]
  4. UNAIDS. AIDS epidemic update : December 2006. Genève, Suisse : UNAIDS, 2006. [Google Scholar]
  5. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5 : 558–67. [Google Scholar]
  6. Shafran SD. Early initiation of antiretroviral therapy : the current best way to reduce liver-related deaths in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2007 online (sois presse). [Google Scholar]
  7. Lagaye S, Derrien M, Menu E, et al. European network for the study of in utero transmission of HIV-1. Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection. J Virol 2001; 75 : 4780–91. [Google Scholar]
  8. Tscherning-Casper C, Papadogiannakis N, Anvret M, et al. The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J Virol 1999; 73 : 9673–8. [Google Scholar]
  9. Mundy DC, Schinazi RF, Gerber AR, et al. Human immunodeficiency virus isolated from amniotic fluid. Lancet 1987; 2 : 459–60. [Google Scholar]
  10. Tuomala RE, O’Driscoll PT, Bremer JW, et al. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis 2003; 187 : 375–84. [Google Scholar]
  11. Mandelbrot L, Burgard M, Teglas JP, et al. Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. AIDS 1999; 13 : 2143–9. [Google Scholar]
  12. Thiry L, Sprecher-Goldberger S, Jonckheer T, et al. Isolation of virus from cell free breast milk of three healthy virus carriers. Lancet 1985; 2 : 891–2. [Google Scholar]
  13. Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 2003; 187 : 741–7. [Google Scholar]
  14. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331 : 1173–80. [Google Scholar]
  15. Perinatal HIV Guidelines Working Group. Public health Service Task Force recommendations for the use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Bethesda, MD : National Institutes of Health, 2006. [Google Scholar]
  16. Soudeyns H, Yao XJ, Gao Q, et al. Anti-HIV-1 activity and in vitro toxicity of 2’-deoxy, 3’-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog. Antimicrob Agents Chemother 1991; 35 : 1386–90. [Google Scholar]
  17. Rodrigues A, Faucher P, Batallan A, et al. Mode of delivery of HIV-infected women : a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004. Gynecol Obstet Fertil 2006; 34 : 304–11. [Google Scholar]
  18. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda : HIVNET 012 randomized trial. Lancet 1999; 354 : 795–802. [Google Scholar]
  19. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard ziduvudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351 : 217–28. [Google Scholar]
  20. Newell ML, Dunn DT, Peckham CS, Semprini AE, Pardi G. Vertical transmission of HIV-1 : maternal immune status and obstetric factors. The European Collaborative Study. AIDS 1996; 10 : 1675–81. [Google Scholar]
  21. Plaeger S, Bermudez S, Mikyas Y, et al. Decreased CD8 cell-mediated viral suppression and other immunologic characteristics of women who transmit human immunodeficiency virus to their infants. J Infect Dis 1999; 179 : 1388–94. [Google Scholar]
  22. Pillay T, Zhang HT, Drijfhout JW, et al. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection. J Virol 2005; 79 : 12100–5. [Google Scholar]
  23. Wu X, Parast AB, Richardson BA, et al. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J Virol 2006; 80 : 835–44. [Google Scholar]
  24. MacDonald KS, Embree J, Njenga S, et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998; 177 : 551–6. [Google Scholar]
  25. Cheynier R, Langlade-Demoyen P, Marescot MR, et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol 1992; 22 : 2211–7. [Google Scholar]
  26. Silvestri G, Soudeyns H, Lapointe N, et al. T-cell receptor Vβ-specific expansions in children from HIV-infected mothers. AIDS 1996; 10 : 549–51. [Google Scholar]
  27. Soudeyns H, Champagne P, Holloway CL, et al. Transient T cell receptor BV-specific expansions of CD4+ and CD8+ T cells during the early phase of pediatric human immunodeficiency virus infection : characterization of expanded cell populations by T cell receptor phenotyping. J Infect Dis 2000; 181 : 107–20. [Google Scholar]
  28. Safrit JT, Ruprecht R, Ferrantelli F, et al. Immunoprophylaxis to prevent mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 2004; 35 : 69–77. [Google Scholar]
  29. Xu W, Hofmann-Lehmann R, McClure HM, et al. Passive immunization with human neutralizing monoclonal antibodies : correlates of protective immunity against HIV. Vaccine 2002; 20 : 1956–60. [Google Scholar]
  30. Binley JM, Wrin T, Korber B, et al. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 2004; 78 : 13232–52. [Google Scholar]
  31. Thomas SL, Newell ML, Peckham CS, Ades AE, Hall AJ. A review of hepatitis C virus (HCV) vertical transmission : risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 1998; 27 : 108–17. [Google Scholar]
  32. Boucher M, Gruslin A, Delage G, et al. The reproductive care of women living with hepatitis C infection – Les soins de santé en reproduction pour les femmes vivant avec l’hépatite C. Health Canada/Santé Canada and/et SOGC Clinical Practice Guidelines / Directives cliniques de la SOGC. J Soc Obstet Gynaecol Can 2000; 22 : 820–44. [Google Scholar]
  33. Mok J, Pembrey L, Tovo PA, Newell ML, European Paediatric Hepatitis C Virus Network. When does mother to child transmission of hepatitis C virus occur ? Arch Dis Child Fetal Neonatal Ed 2005; 90 : 156–60. [Google Scholar]
  34. Ioannidis JP, Abrams EJ, Ammann A, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads < 1000 copies/ml. J Infect Dis 2001; 183 : 539–45. [Google Scholar]
  35. King NJ, Maxwell LE, Kesson AM. Induction of class I major histocompatibility complex antigen expression by West Nile virus on gamma interferon-refractory early murine trophoblast cells. Proc Natl Acad Sci USA 1989; 86 : 911–5. [Google Scholar]
  36. Chi BH, Mudenda V, Levy J, et al. Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus type 1 transmission. Am J Obs Gynecol 2006; 194 : 174–81. [Google Scholar]
  37. Lauer GM, Nguyen TN, Day CL et al. Human immunodeficiency type 1-hepatitis C virus co-infection : intraindividual comparison of cellular immune responses against two persistent viruses. J Virol 2002; 76 : 2817–26. [Google Scholar]
  38. Gervais A, Bacq Y, Bernuau J, et al. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 2000; 32 : 293–9. [Google Scholar]
  39. Canobio S, Guilbert C, Troesch M, et al. Differing patterns of liver disease progression and hepatitis C virus (HCV) quasi species evolution in children vertically co-infected with HCV and human immunodeficiency virus type 1. J Clin Microbiol 2004; 42 : 4365–9. [Google Scholar]
  40. Troesch M, Jalbert E, Canobio S, et al. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in patients co-infected with hepatitis C virus and HIV-1. AIDS 2005; 19 : 775–84. [Google Scholar]
  41. Troesch M, Meunier I, Lapierre P, et al. Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein. Virology 2006; 352 : 357–67. [Google Scholar]
  42. Ferm VH, Willhite C, Kilham L. Teratogenic effects of ribavirin on hamster and rat embryos. Teratology 1978; 17 : 93–101. [Google Scholar]
  43. Dubois J, Hershon L, Carmant L, et al. Toxicity profile of interferon alfa-2b in children : A prospective evaluation. J Pediatr 1999; 135 : 782–5. [Google Scholar]
  44. Akouamba BS, Viel J, Charest H, et al. HIV-1 genetic diversity in antenatal cohort, Canada. Emerg Infect Dis 2005; 11 : 1230–4. [Google Scholar]
  45. Ozaslan E, Yilmaz R, Simsek H, Tatar G. Interferon therapy for acute hepatitis C during pregnancy. Ann Pharmacother 2002; 36 : 1715–8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.